Literature DB >> 15728826

APL during gefitinib treatment for non-small-cell lung cancer.

Akiko Uchida, Keitaro Matsuo, Mitsune Tanimoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728826     DOI: 10.1056/NEJM200502243520825

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  A case of acute promyelocytic leukemia during gefitinib treatment.

Authors:  Daisuke Ennishi; Nobuo Sezaki; Tadasi Senoo; Yasuhito Terui; Kiyohiko Hatake; Norihiko Hino
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

2.  Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.

Authors:  Huabin Wang; Yin Yin; Ru Wang; Junbin Huang; Hongman Xue; Yucai Cheng; Lidan Zhang; Chun Chen
Journal:  BMC Cancer       Date:  2020-11-10       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.